Finn C Wiberg

Title: **Finn C Wiberg: Innovator of Recombinant Polyclonal Proteins**

Introduction

Finn C Wiberg, a distinguished inventor based in Farum, Denmark, has significantly contributed to the field of biotechnology through his innovative work. With a total of four patents to his name, Wiberg's research primarily focuses on methods for manufacturing recombinant polyclonal proteins, showcasing his expertise in therapeutic antibody development.

Latest Patents

Among his latest patents, Wiberg has developed a groundbreaking method for manufacturing recombinant polyclonal protein compositions, specifically targeting recombinant polyclonal antibody compositions. This innovative method involves obtaining a collection of cells that are transfected with a library of variant nucleic acid sequences. Each cell in this collection expresses a distinct member of a polyclonal protein that binds to a specific antigen. This technology allows for the production of superior therapeutic immunoglobulin products, offering a promising alternative to traditional plasma-derived products.

Additionally, he has refined a method for manufacturing a recombinant polyclonal protein, which also utilizes a collection of variant nucleic acid sequences. By introducing these nucleic acid sequences into cells via transfection with a collection of vectors, the cells can be cultured to express the desired polyclonal protein. This method holds significant potential for therapeutic applications, enhancing the availability of recombinant polyclonal antibodies.

Career Highlights

Wiberg's career includes tenure with notable companies such as Novo Nordisk A/S and Symphogen A/S. His work in these organizations has allowed him to leverage his skills in genetic engineering and protein production, further solidifying his reputation as an expert in the field.

Collaborations

Throughout his career, Wiberg has collaborated with various talented professionals, including Else Marie Nicolaisen and So Slashedren Bjo Slashedrn. These partnerships have contributed to the refinement of his methodologies and the successful development of his patented technologies.

Conclusion

Finn C Wiberg stands as a notable figure in biotechnology, recognized for his innovative methods for producing recombinant polyclonal proteins. His inventions not only advance scientific understanding but also pave the way for improved therapeutic options, demonstrating the profound impact of his work on modern medicine.